Zymeworks Inc. Common Stock (ZYME)
Healthcare
Biotechnology
21.90 $
-3.4%
vs. previous close
Closing price · As of: 31. Jul 2026
Zymeworks Inc. Common Stock (ZYME) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -33 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.0 | -22 | -35 | 0.2 | 24 | -82 | -151 | -192 | 144 | -118 | -110 | -33 | |
| 0.4 | 0.5 | 1.0 | 2.7 | 3.6 | 7.3 | 10 | 9.6 | 12 | 17 | 11 | 11 | |
| 0.6 | 1.4 | 4.3 | 3.4 | 13 | 49 | 29 | 11 | 4.0 | 8.1 | 18 | 28 | |
| 0.9 | 1.4 | -0.1 | 6.1 | 17 | 50 | 29 | 9.2 | 3.7 | – | – | – | |
| 4.6 | -4.9 | -2.4 | 1.8 | 40 | 6.4 | -10 | 0.4 | 4.0 | -26 | -31 | 7.5 | |
| 0.3 | 0.9 | 5.5 | 3.1 | 3.4 | 14 | 6.3 | 13 | 13 | 4.1 | 3.1 | 1.5 | |
| -0.3 | -9.2 | -25 | -31 | -109 | -26 | -43 | 145 | -54 | -207 | 39 | 27 | |
| – | – | – | – | – | 0.6 | 1.1 | – | – | 814 | – | – | |
| 47 | 1.9 | 59 | 58 | 91 | 0.6 | 1.1 | 2.1 | 1.4 | 820 | -30 | -42 | |
| 0.0 | 0.0 | 6.9 | -7.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | |
| 46 | 1.5 | 65 | 50 | 91 | 194 | 309 | 8.0 | 109 | 82 | -20 | -19 | |
| 38 | -35 | 4.9 | 20 | 6.3 | 86 | 114 | -40 | 199 | -243 | -91 | -25 | |
| -7.3 | -23 | -41 | -2.9 | 21 | -96 | -158 | -206 | 131 | -122 | -113 | -35 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.